|
Characteristic
|
All RA patients (n = 42)
|
RA patients with a 1-year follow up (n = 20)
|
P
|
|---|
|
Age (years)
|
46.81 ± 10.78
|
48.05 ± 9.47
|
0.51
|
|
Sex (% female)
|
83 ± 11.27
|
70 ± 20.08
|
0.38
|
|
Disease duration (years)
|
8.98 ± 8.39
|
8.80 ± 8.01
|
0.82
|
|
Previous DMARD treatment (n)
|
2.78 ± 1.41
|
2.70 ± 2.70
|
0.47
|
|
Swollen joint count (0–28)
|
4.57 ± 3.16
|
4.55 ± 2.70
|
0.43
|
|
Tender joint count (0–28)
|
9.21 ± 5.78
|
8.35 ± 6.07
|
0.80
|
|
DAS28 score
|
5.33 ± 1.12
|
5.31 ± 1.19
|
0.76
|
|
ESR (mm/hour)
|
37.59 ± 23.18
|
37.45 ± 23.71
|
0.91
|
|
CRP (mg/l)
|
26.93 ± 24.87
|
31.30 ± 27.24
|
0.65
|
- Values are expressed as mean ± standard deviation. CRP, C-reactive protein; DAS28, Disease Activity Score 28; DMARD, disease-modifying antirheumatic drug; ESR, erythrocyte sedimentation rate; RA, rheumatoid arthritis.
